Open Orphan PLC's (LON:ORPH) Cathal Friel presents at the Proactive One2One Virtual October Conference.
The company's a rapidly growing specialist CRO pharmaceutical services company which is a world leader in the testing of vaccines and antivirals through the use of human challenge clinical trials.
It has Europe's only 24-bedroom quarantine clinic with onsite virology lab in Queen Mary's Hospital London.